We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain Cancer

News   Feb 14, 2012

 
Diffusion Pharmaceuticals Begins Clinical Trial for Treatment of Primary Brain Cancer
 
 
 

RELATED ARTICLES

Prescription Omega-3 Fatty Acid Meds Lower High Triglycerides by 20–30%

News

Prescription omega-3 fatty acid medication reduces triglyceride levels by 20-30% among the majority of people who require treatment for high triglyceride levels, according to a science advisory from the American Heart Association.

READ MORE

In Melanoma, Numbers Count

News

University of Queensland scientists have identified a way to help dermatologists determine a patient's risk of developing melanoma.

READ MORE

Study Suggests a Lack of Racial Diversity in Cancer Drug Trials

News

A new study has found that fewer than 8% of cancer drug trials reported participation from the four major races in the United States – white, Asian, black and Hispanic – between 2008 and 2018.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Drug Discovery

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE